Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The First Affiliated Hospital of Soochow University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Irvine
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Bristol-Myers Squibb
Center for International Blood and Marrow Transplant Research
Beth Israel Deaconess Medical Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
University of Illinois at Chicago
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Centre Antoine Lacassagne
Washington University School of Medicine
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
City of Hope Medical Center
M.D. Anderson Cancer Center
Washington University School of Medicine
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
OncoVerity, Inc.
St. Jude Children's Research Hospital
City of Hope Medical Center
Case Comprehensive Cancer Center
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Institut Paoli-Calmettes
Institut Paoli-Calmettes
PrECOG, LLC.
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Groupe Francophone des Myelodysplasies
University of Virginia
Ryvu Therapeutics SA